{
  "id": "NGN_SA_CD_001",
  "caseID": "PSYCHM-500-75-1771347644356",
  "itemType": "clozeDropdown",
  "question": "The nurse reviews the client's most recent data. The nurse recognizes the client is developing ___[1]___. Therefore, the nurse's priority action is to ___[2]___.",
  "stem": {
    "tabs": [
      {
        "title": "Nurses' Notes",
        "content": "A 36-year-old client, G3P2 at 34 weeks gestation, was admitted 12 hours ago for induction of labor due to preeclampsia with severe features. A continuous infusion of magnesium sulfate is infusing peripherally. The client has a history of a previous deep vein thrombosis (DVT) with her last pregnancy. She reports inconsistent prenatal care due to relying on family for transportation. \n\n**Current Note:** At 0100, client suddenly reports intense, constant 10/10 abdominal pain that she describes as 'a tearing feeling.' Uterus is rigid and tender to palpation between contractions. Moderate amount of dark red vaginal bleeding noted. Fetal heart rate tracing shows persistent late decelerations with minimal variability. Provider at bedside, notified of findings. Emergency Cesarean section is being prepared. STAT labs drawn."
      },
      {
        "title": "Vital Signs",
        "content": [
          {
            "time": "1800 (Admission)",
            "BP": "162/110 mmHg",
            "HR": "88 bpm",
            "RR": "18/min",
            "Temp": "37.0°C (98.6°F)",
            "O2 Sat": "98%"
          },
          {
            "time": "2200",
            "BP": "158/105 mmHg",
            "HR": "92 bpm",
            "RR": "16/min",
            "Temp": "37.1°C (98.8°F)",
            "O2 Sat": "97%"
          },
          {
            "time": "0100 (Current)",
            "BP": "105/60 mmHg",
            "HR": "124 bpm",
            "RR": "24/min",
            "Temp": "36.8°C (98.2°F)",
            "O2 Sat": "94%"
          }
        ]
      },
      {
        "title": "Laboratory Results",
        "content": {
          "Test": [
            "Hemoglobin",
            "Hematocrit",
            "Platelet Count",
            "Fibrinogen",
            "D-dimer",
            "PT",
            "aPTT",
            "Magnesium Level"
          ],
          "Result": [
            "9.1 g/dL",
            "27%",
            "68,000/mm³",
            "95 mg/dL",
            ">5,000 ng/mL",
            "22 seconds",
            "48 seconds",
            "6.8 mg/dL"
          ],
          "Reference Range": [
            "12.0-16.0 g/dL",
            "36-48%",
            "150,000-400,000/mm³",
            "200-400 mg/dL",
            "<250 ng/mL",
            "11-13.5 seconds",
            "30-40 seconds",
            "4.0-7.0 mg/dL (Therapeutic)"
          ]
        }
      },
      {
        "title": "Medication Administration Record (MAR)",
        "content": [
          {
            "Medication": "Magnesium Sulfate IV",
            "Dose": "2 g/hr",
            "Route": "Continuous Infusion",
            "Status": "Infusing"
          },
          {
            "Medication": "Labetalol IV",
            "Dose": "20 mg",
            "Route": "IV Push",
            "Frequency": "PRN for SBP > 160 or DBP > 110",
            "Status": "Available"
          },
          {
            "Medication": "Enoxaparin SubQ",
            "Dose": "40 mg",
            "Route": "Subcutaneous",
            "Frequency": "Daily",
            "Status": "Due Now"
          }
        ]
      }
    ]
  },
  "options": [
    {
      "blank": "[2]",
      "choices": [
        "administer the prescribed labetalol",
        "increase the magnesium sulfate infusion rate",
        "withhold the scheduled dose of enoxaparin"
      ]
    },
    {
      "blank": "[1]",
      "choices": [
        "HELLP syndrome",
        "disseminated intravascular coagulation (DIC)",
        "amniotic fluid embolism"
      ]
    }
  ],
  "correctAnswer": [
    1,
    2
  ],
  "scoring": {
    "type": "+-",
    "points": 1
  },
  "answerBreakdown": [
    {
      "blank": "[1]",
      "options": [
        {
          "text": "HELLP syndrome",
          "isCorrect": false,
          "rationale": "Incorrect. HELLP syndrome (Hemolysis, Elevated Liver enzymes, Low Platelets) is a complication of preeclampsia. While the client has thrombocytopenia, the critically low fibrinogen, markedly elevated D-dimer, and prolonged PT/aPTT are more indicative of disseminated intravascular coagulation (DIC). HELLP does not typically present with this specific coagulation profile.",
          "pathophysiology": "HELLP syndrome is characterized by liver inflammation and microangiopathic hemolytic anemia. The liver damage leads to elevated liver enzymes, and the hemolysis results in anemia. Low platelets are due to increased consumption and destruction. DIC involves widespread activation of the coagulation cascade, leading to consumption of clotting factors and subsequent bleeding.",
          "clinicalPearl": "Differentiating HELLP from DIC is crucial. HELLP primarily affects the liver and blood cells, while DIC is a systemic coagulation disorder. Look for the classic triad of hemolysis, elevated liver enzymes, and low platelets in HELLP. In DIC, look for signs of both clotting and bleeding, along with abnormal coagulation studies."
        },
        {
          "text": "disseminated intravascular coagulation (DIC)",
          "isCorrect": true,
          "rationale": "Correct. The client's presentation strongly suggests disseminated intravascular coagulation (DIC) secondary to placental abruption. The laboratory results show profound thrombocytopenia (platelets 68,000/mm³), hypofibrinogenemia (fibrinogen 95 mg/dL), a massively elevated D-dimer (>5,000 ng/mL), and prolonged clotting times (PT 22 seconds, aPTT 48 seconds). These findings indicate widespread activation of the clotting cascade and subsequent consumption of clotting factors, leading to both thrombosis and hemorrhage. The rigid, tender uterus and dark red bleeding are consistent with placental abruption, a common trigger for DIC in pregnancy.",
          "pathophysiology": "Placental abruption causes the release of tissue factor into the maternal circulation, triggering the extrinsic coagulation pathway. This leads to the formation of microthrombi throughout the vasculature, consuming platelets and clotting factors. The body's attempt to break down these clots results in the release of fibrin degradation products, including D-dimer. The consumption of clotting factors and platelets leads to a state of coagulopathy and increased risk of bleeding.",
          "clinicalPearl": "DIC is a life-threatening condition requiring prompt recognition and treatment. The underlying cause must be addressed (in this case, placental abruption), and supportive measures such as blood product transfusion (platelets, cryoprecipitate, fresh frozen plasma) are essential to restore hemostasis. Monitor the client closely for signs of bleeding and thrombosis."
        },
        {
          "text": "amniotic fluid embolism",
          "isCorrect": false,
          "rationale": "Incorrect. Amniotic fluid embolism (AFE) is a rare, catastrophic event that typically presents with sudden cardiovascular collapse, respiratory distress, and seizures. While AFE can also cause DIC, the client's initial presentation of severe, constant abdominal pain, a rigid uterus, and dark red bleeding is more consistent with a severe placental abruption, which then triggered DIC. The onset of AFE is usually more acute and dramatic.",
          "pathophysiology": "Amniotic fluid embolism occurs when amniotic fluid, fetal cells, and other debris enter the maternal circulation, triggering an anaphylactoid reaction and activation of the coagulation cascade. This leads to pulmonary vasoconstriction, right ventricular failure, and subsequent cardiovascular collapse. DIC can develop as a secondary complication due to the activation of the coagulation system.",
          "clinicalPearl": "AFE is a clinical diagnosis based on the sudden onset of respiratory distress, cardiovascular collapse, and coagulopathy during labor or immediately postpartum. It is a medical emergency requiring immediate resuscitation and supportive care."
        }
      ]
    },
    {
      "blank": "[2]",
      "options": [
        {
          "text": "administer the prescribed labetalol",
          "isCorrect": false,
          "rationale": "Incorrect. The client's current blood pressure is 105/60 mmHg, which is hypotensive, likely from hemorrhagic shock due to the abruption and DIC. Administering an antihypertensive like labetalol is contraindicated and would cause further dangerous hypotension, potentially leading to cardiovascular collapse.",
          "pathophysiology": "Labetalol is a beta-adrenergic and alpha-adrenergic blocker that lowers blood pressure by decreasing peripheral vascular resistance and heart rate. In a client who is already hypotensive due to blood loss, further reducing blood pressure can compromise tissue perfusion and exacerbate shock.",
          "clinicalPearl": "Always assess the client's hemodynamic status before administering antihypertensive medications. Hypotension is a contraindication to antihypertensive therapy. Focus on addressing the underlying cause of the hypotension, such as fluid resuscitation and blood product transfusion."
        },
        {
          "text": "increase the magnesium sulfate infusion rate",
          "isCorrect": false,
          "rationale": "Incorrect. The client's magnesium level is 6.8 mg/dL, which is within the therapeutic range (4.0-7.0 mg/dL) for seizure prophylaxis in preeclampsia. Increasing the rate would risk magnesium toxicity (loss of deep tendon reflexes, respiratory depression, cardiac arrest) without addressing the life-threatening hemorrhage and coagulopathy.",
          "pathophysiology": "Magnesium sulfate is a central nervous system depressant used to prevent seizures in preeclampsia. However, excessive magnesium levels can lead to neuromuscular blockade and respiratory depression.",
          "clinicalPearl": "Monitor magnesium levels closely during magnesium sulfate infusion. Assess for signs of magnesium toxicity, such as loss of deep tendon reflexes, decreased respiratory rate, and altered mental status. Have calcium gluconate available as an antidote for magnesium toxicity."
        },
        {
          "text": "withhold the scheduled dose of enoxaparin",
          "isCorrect": true,
          "rationale": "Correct. This is the critical 'DON'T PROCEED' / 'SAFETY STOP' action. Enoxaparin is a low-molecular-weight heparin (LMWH), an anticoagulant. Administering it to a client with an active placental abruption, hemorrhagic shock (tachycardia, hypotension), and active DIC would be catastrophic and would potentiate life-threatening hemorrhage. The standing order for DVT prophylaxis is now contraindicated by the acute clinical change. The priority is to stabilize the client's coagulopathy and control the bleeding.",
          "pathophysiology": "Enoxaparin inhibits the formation of blood clots by potentiating antithrombin, which inactivates several clotting factors. In a client with DIC, the coagulation system is already dysregulated, and administering an anticoagulant would further impair the body's ability to form clots and stop the bleeding.",
          "clinicalPearl": "In the presence of active bleeding or coagulopathy, anticoagulants are contraindicated. Always assess the client's coagulation status before administering anticoagulants. Prioritize interventions to control bleeding and restore hemostasis."
        }
      ]
    }
  ],
  "meta": {
    "version": "1.0",
    "NCSBN_Client_Needs": "Safe and Effective Care Environment",
    "NCSBN_Subcategory": "Safety and Infection Control",
    "NCLEX_Cognitive_Level": "Analyze/Evaluate",
    "NCLEX_Process": "Nursing Process (Implementation)",
    "topic": "Maternal-Newborn/Placenta Abruption",
    "difficulty": "Level 4-5 (Highly Discriminating)",
    "seed": "MISSION-500-75-1771347644356",
    "standards": [
      "2026",
      "Health Equity"
    ],
    "psychometrician": "Elite NCLEX-RN NGN Psychometrician & Content Scientist"
  },
  "sentinelStatus": "healed_v2026_v8"
}